- For 1H24, Raffles Medical Group (SGX:BSL) reported lower y-o-y revenue (-1.4% y-o-y) due to the absence of COVID-19-related revenue but higher revenue on a sequential basis (+8.8% h-o-h), driven by better revenue contributions from the hospital services and insurance segments.
Results slightly below expectations.
- - Read this at SGinvestors.io -
- The underperformance was due to lower margins from higher operating expenses and lower-than-expected other operating income (-S$6m y-o-y). The lower other operating income was largely due to lower Wage Credit payout and Jobs Growth Incentive grant received in 1H24.
- - Read this at SGinvestors.io -
Softer but stabilising margins.
- 1H24 EBITDA (-9.0ppt y-o-y, -0.6ppt h-o-h) and PATMI (- 7.8ppt y-o-y, -0.6ppt h-o-h) margins were softer due to the absence of higher-margin COVID-19 revenue, increased insurance expenses and operating expenses.
- 1H24 staff costs was largely stable (+0.2ppt y-o-y, +0.7ppt h-o-h) at 42% of turnover. However, driven by the ongoing shortage of nurses in Singapore, we expect staff costs as a percentage of turnover to normalise closer to the historical pre-pandemic level of 50% moving forward.
Healthcare services: Strong sequential performance and improved outlook.
- Read more at SGinvestors.io.
Above is the excerpt from report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full report in PDF @ https://www.utrade.com.sg/.
Llelleythan Tan UOB Kay Hian Research | Heidi Mo UOB Kay Hian | https://research.uobkayhian.com/ 2024-07-30
Previous report by UOB:
2024-02-27 Raffles Medical - Weaker 2023 Margins In Line With Expectations; Headwinds Persist.
Price targets by other brokers at Raffles Medical Target Prices.
Listing of research reports at Raffles Medical Analyst Reports.
Relevant links:
Raffles Medical Share Price History,
Raffles Medical Announcements,
Raffles Medical Dividends & Corporate Actions,
Raffles Medical News Articles